TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $6,412,000 | -10.9% | 4,588,500 | -5.6% | 0.01% | -16.7% |
| Q1 2015 | $7,197,000 | -0.3% | 4,863,000 | -8.0% | 0.01% | -14.3% |
| Q4 2014 | $7,218,000 | +1.3% | 5,283,000 | -4.8% | 0.01% | -12.5% |
| Q3 2014 | $7,122,000 | -4.1% | 5,548,000 | -4.5% | 0.01% | -11.1% |
| Q2 2014 | $7,428,000 | -0.6% | 5,812,000 | -1.3% | 0.01% | -10.0% |
| Q1 2014 | $7,475,000 | +21.1% | 5,888,000 | +1.3% | 0.01% | +25.0% |
| Q4 2013 | $6,173,000 | -0.5% | 5,813,000 | -2.8% | 0.01% | -11.1% |
| Q3 2013 | $6,202,000 | -1.9% | 5,981,000 | -0.9% | 0.01% | -10.0% |
| Q2 2013 | $6,319,000 | – | 6,033,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |